[1] F. Raza, H. Zafar, X. You, A. Khan, J. Wu, L. Ge, Cancer nanomedicine: focus on recent developments and self-assembled peptide nanocarriers, J Mater Chem B 7(48) (2019) 7639-7655.
[2] F. Raza, H. Zafar, Y. Zhu, Y. Ren, A. Ullah, A.U. Khan, X. He, H. Han, M. Aquib, K.O. Boakye-Yiadom, A review on recent
advances in stabilizing peptides/proteins upon fabrication in hydrogels from biodegradable polymers, Pharmaceutics 10(1) (2018) 16.
[3] F. Raza, Y. Zhu, L. Chen, X. You, J. Zhang, A. Khan, M.W. Khan, M. Hasnat, H. Zafar, J. Wu, Paclitaxel-loaded pH-responsive hydrogel based on self-assembled peptides for tumor targeting, Biomater. Sci.7(5) (2019) 2023-2036.
[4] Y. Zhu, L. Wang, Y. Li, Z. Huang, S. Luo, Y. He, H. Han, F. Raza, J. Wu, L. Ge, Injectable pH and redox dual responsive hydrogel based on self-assembled peptides for anti-tumor drug delivery, Biomater. Sci., 8(2020) 5415-5426.
[5] F. Raza, H. Zafar, S. Zhang, Z. Kamal, J. Su, W.E. Yuan, Q. Mingfeng, Recent Advances in Cell Membrane‐Derived Biomimetic Nanotechnology for Cancer Immunotherapy, Adv. Healthc. Mater. 10(6) (2021) 2002081.
[6] G. Heidari, M. Hassanpour, F. Nejaddehbashi, M.R. Sarfjoo, S. Yousefiasl, E. Sharifi, A. Bigham, T. Agarwal, A. Borzacchiello, E.J.M.C.H. Lagreca, Biosynthesized nanomaterials with antioxidant and antimicrobial properties, Mater. Chem. Horizons 1(1) (2022) 35-48.
[7] Z. Islamipour, E.N. Zare, F. Salimi, M. Ghomi, P. Makvandi, Biodegradable antibacterial and antioxidant nanocomposite films based on dextrin for bioactive food packaging, J. Nanostructure Chem. 12(2022)991–1006.
[8] S. Yousefiasl, H. Manoochehri, P. Makvandi, S. Afshar, E. Salahinejad, P. Khosraviyan, M. Saidijam, S. Soleimani Asl, E. Sharifi, Chitosan/alginate bionanocomposites adorned with mesoporous silica nanoparticles for bone tissue engineering, J. Nanostructure Chem. (2022) 1-15.
[9] G. Heidari, M. Hassanpour, F. Nejaddehbashi, M.R. Sarfjoo, S. Yousefiasl, E. Sharifi, A. Bigham, T. Agarwal, A. Borzacchiello, E. Lagreca, Biosynthesized Nanomaterials with Antioxidant and Antimicrobial Properties, Mater. Chem. Horizons 1(1) (2022) 35-48.
[10] L. Wang, J. Cao, T. Liu, Z. Xu, B. Yang, T. Huang, X. Jiang, N. Wu, Recent advances on the magnetic nanoparticle–based
nanocomposites for magnetic induction hyperthermia of tumor: a short review, Adv. Compos. Hybrid Mater. 4(4) (2021) 925-937.
[11] W. Jia, Y. Qi, Z. Hu, Z. Xiong, Z. Luo, Z. Xiang, J. Hu, W. Lu, Facile fabrication of monodisperse CoFe2O4
nanocrystals@dopamine@DOX hybrids for magnetic-responsive on-demand cancer theranostic applications, Adv. Compos. Hybrid Mater. 4(4) (2021) 989-1001.
[12] S. Hajebi, S. Yousefiasl, I. Rahimmanesh, A. Dahim, S. Ahmadi, F.B. Kadumudi, N. Rahgozar, S. Amani, A. Kumar, E. Kamrani, Genetically Engineered Viral Vectors and Organic‐Based Non‐Viral Nanocarriers for Drug Delivery Applications, Adv. Healthc. Mater. (2022) 2201583.
[13] Z. Cheng, S. Liu, X. Wu, F. Raza, Y. Li, W. Yuan, M. Qiu, J. Su, Autologous erythrocytes delivery of berberine hydrochloride with long-acting effect for hypolipidemia treatment, Drug Deliv. 27(1) (2020) 283-291.
[14] Y. Lian, X. Wang, P. Guo, Y. Li, F. Raza, J. Su, M. Qiu, Erythrocyte membrane-coated arsenic trioxide-loaded sodium alginate nanoparticles for tumor therapy, Pharmaceutics 12(1) (2020) 21.
[15] Z. Hussain, M.A. Rahim, N. Jan, H. Shah, M. Rawas-Qalaji, S. Khan, M. Sohail, H.E. Thu, N.A. Ramli, R.M. Sarfraz, Cell
membrane cloaked nanomedicines for bio-imaging and immunotherapy of cancer: Improved pharmacokinetics, cell
internalization and anticancer efficacy, J Control Release 335 (2021) 130-157.
[16] J. Lopes, D. Lopes, M. Pereira‐Silva, D. Peixoto, F. Veiga, M.R. Hamblin, J. Conde, C. Corbo, E.N. Zare, M. Ashrafizadeh,
Macrophage Cell Membrane‐Cloaked Nanoplatforms for Biomedical Applications, Small Methods (2022) 2200289.
[17] I. Ferreira-Faria, S. Yousefiasl, A. Macário-Soares, M. Pereira-Silva, D. Peixoto, H. Zafar, F. Raza, H. Faneca, F. Veiga, et
al.Hamblin, Stem cell membrane-coated abiotic nanomaterials for biomedical applications, J Control Release 351(2022)174-197.
[18] H.-Y. Chen, J. Deng, Y. Wang, C.-Q. Wu, X. Li, H.-W. Dai, Hybrid cell membrane-coated nanoparticles: A multifunctional biomimetic platform for cancer diagnosis and therapy, Acta biomater. 112 (2020) 1-13.
[19] X. Wu, Y. Li, F. Raza, X. Wang, S. Zhang, R. Rong, M. Qiu, J. Su, Red Blood Cell Membrane-Camouflaged Tedizolid
Phosphate-Loaded PLGA Nanoparticles for Bacterial-Infection Therapy, Pharmaceutics 13(1) (2021) 99.
[20] E. Xu, X. Wu, X. Zhang, K. Zul, F. Raza, J. Su, M. Qiu, Study on the protection of dextran on erythrocytes during drug loading, Colloids Surf. B: Biointerfaces. 189 (2020) 110882.
[21] Z. Chen, Z. Wang, Z. Gu, Bioinspired and biomimetic nanomedicines, Acc. Chem. Res. 52(5) (2019) 1255-1264.
[22] V. Vijayan, S. Uthaman, I.-K. Park, Cell Membrane-Camouflaged Nanoparticles: A Promising Biomimetic Strategy for Cancer Theragnostics, Polymers 10(9) (2018) 983.
[23] Q. Xia, Y. Zhang, Z. Li, X. Hou, N. Feng, Red blood cell membrane-camouflaged nanoparticles: A novel drug delivery system for antitumor application, Acta Pharm. Sin. B. B 9(4) (2019) 675-689.
[24] Z. Kamal, J. Su, W. Yuan, F. Raza, L. Jiang, Y. Li, M.Qiu, Technology, Red blood cell membrane-camouflaged vancomycin and chlorogenic acid-loaded gelatin nanoparticles against multi-drug resistance infection mice model, J Drug Deliv Sci Technol. 76 (2022) 103706.
[25] R. Rong, F. Raza, Y. Liu, W.-e. Yuan, J. Su, M.Qiu, Biopharmaceutics, Blood cell-based drug delivery systems: a biomimetic platform for antibacterial therapy, Eur. J. Pharm. Biopharm. 177(2022) 273-288.
[26] M. Fan, M. Jiang, Core-shell nanotherapeutics with leukocyte membrane camouflage for biomedical applications, J Drug Deliv Sci Technol. 28(9) (2020) 873-881.
[27] J. Feng, S. Wang, Y. Wang, L. Wang, Stem cell membrane–camouflaged bioinspired nanoparticles for targeted photodynamic therapy of lung cancer, J. Nanoparticle Res. 22(7) (2020) 1-11.
[28] S.S. Kunde, S. Wairkar, Platelet membrane camouflaged nanoparticles: biomimetic architecture for targeted therapy, Int. J. Pharm. 598 (2021) 120395.
[29] S. Ghosh, K. Girigoswami, A. Girigoswami, Membrane-encapsulated camouflaged nanomedicines in drug delivery,
Nanomedicine 14(15) (2019) 2067-2082.
[30] M. Perreau, R. Banga, G.J.T.i.m.m. Pantaleo, Targeted immune interventions for an HIV-1 cure, Trends Mol Med 23(10) (2017) 945-961.
[31] E.M. Campbell, T.J.J.N.R.M. Hope, HIV-1 capsid: the multifaceted key player in HIV-1 infection, Nat Rev Microbiol. 13(8) (2015) 471-483.
[32] M.S. Dahabieh, E. Battivelli, E.J.A.Verdin, Understanding HIV latency: the road to an HIV cure, Annu Rev Med.66 (2015) 407- 421.
[33] N. Rabiee, Y. Fatahi, S. Ahmadi, N. Abbariki, A. Ojaghi, M. Rabiee, F. Radmanesh, R. Dinarvand, M. Bagherzadeh, E.
Mostafavi, Bioactive hybrid metal-organic framework (MOF)-based nanosensors for optical detection of recombinant SARSCoV-2 spike antigen, Sci Total Environ 825 (2022) 153902.
[34] C. Beyrer, A.J.N.E.J.o.M. Pozniak, HIV drug resistance—an emerging threat to epidemic control, N Engl J Med 377(17) (2017) 1605-1607.
[35] L. Xu, A. Pegu, E. Rao, N. Doria-Rose, J. Beninga, K. McKee, D.M. Lord, R.R. Wei, G. Deng, M.J.S. Louder, Trispecific
broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques, Science 358(6359) (2017) 85-90.
[36] L.E. McCoy, D.R.J.I.r. Burton, Identification and specificity of broadly neutralizing antibodies against HIV, Immunol Rev 275(1) (2017) 11-20.
[37] G.K. Lewis, M. Pazgier, A.L.J.I.r. DeVico, Survivors remorse: antibody‐mediated protection against HIV‐1, Immunol Rev
275(1) (2017) 271-284.
[38] D.K. Wijesundara, C. Ranasinghe, B. Grubor-Bauk, E.J.J.F.i.M. Gowans, Emerging targets for developing T cell-mediated vaccines for human immunodeficiency virus (HIV)-1, Front Microbiol 8 (2017) 2091.
[39] M.S. Gebre, L.A. Brito, L.H. Tostanoski, D.K. Edwards, A. Carfi, D.H.J.C. Barouch, Novel approaches for vaccine
development,Cell 184(6) (2021) 1589-1603.
[40] J.J. Glass, S.J. Kent, R.J.E.R.o.V. De Rose, Enhancing dendritic cell activation and HIV vaccine effectiveness through
nanoparticle vaccination, Expert Rev Vaccines. 15(6) (2016) 719-729.
[41] J. das Neves, R. Nunes, F. Rodrigues, B.J.A.D.D.R. Sarmento, Nanomedicine in the development of anti-HIV microbicides, Adv Drug Deliv Rev 103 (2016) 57-75.
[42] L.N. Ramana, A.R. Anand, S. Sethuraman, U.M.J.J.o.c.r. Krishnan, Targeting strategies for delivery of anti-HIV drugs, J Control Release 192 (2014) 271-283.
[43] S.K. Adesina, E.O.J.M.p. Akala, Nanotechnology approaches for the delivery of exogenous siRNA for HIV therapy, Mol.
Pharmaceutics 12(12) (2015) 4175-4187.
[44] V. Mishra, P. Kesharwani, N.K.J.D.D.T. Jain, siRNA nanotherapeutics: a Trojan horse approach against HIV, Drug Discov
19(12) (2014) 1913-1920.
[45] J.H. Park, A. Mohapatra, J. Zhou, M. Holay, N. Krishnan, W. Gao, R.H. Fang, L.J.A.C. Zhang, Virus‐mimicking cell membrane‐ coated nanoparticles for cytosolic delivery of mRNA, Angew Chem Int Ed Engl 134(2) (2022) e202113671.
[46] J.A. Copp, R.H. Fang, B.T. Luk, C.-M.J. Hu, W. Gao, K. Zhang, L.J.P.o.t.N.A.o.S. Zhang, Clearance of pathological antibodies using biomimetic nanoparticles, PNAS 111(37) (2014) 13481-13486.
[47] S. Thamphiwatana, P. Angsantikul, T. Escajadillo, Q. Zhang, J. Olson, B.T. Luk, S. Zhang, R.H. Fang, W. Gao, V.J.P.o.t.N.A.o.S. Nizet, Macrophage-like nanoparticles concurrently absorbing endotoxins and proinflammatory cytokines for sepsis management, PNAS 114(43) (2017) 11488-11493.
[48] H. Gong, Q. Zhang, A. Komarla, S. Wang, Y. Duan, Z. Zhou, F. Chen, R.H. Fang, S. Xu, W.J.N.L. Gao, Nanomaterial
biointerfacing via mitochondrial membrane coating for targeted detoxification and molecular detection, Nano Lett. 21(6) (2021) 2603-2609.
[49] X. Wei, G. Zhang, D. Ran, N. Krishnan, R.H. Fang, W. Gao, S.A. Spector, L.J.A.M. Zhang, T‐cell‐mimicking nanoparticles can neutralize HIV infectivity, Adv Mater. 30(45) (2018) 1802233.
[50] G. Zhang, G.R. Campbell, Q. Zhang, E. Maule, J. Hanna, W. Gao, L. Zhang, S.A.J.M. Spector, CD4+ t cell-mimicking
nanoparticles broadly neutralize hiv-1 and suppress viral replication through autophagy, mBio.11(5) (2020) e00903-20.
[51] J. Zhao, J. Ruan, G. Lv, Q. Shan, Z. Fan, H. Wang, Y. Du, L.J.C. Ling, S.B. Biointerfaces, Cell membrane-based biomimetic
nanosystems for advanced drug delivery in cancer therapy: A comprehensive review, Colloids Surf. B: Biointerfaces (2022)
112503.
[52] L. Liu, X. Bai, M.-V. Martikainen, A. Kårlund, M. Roponen, W. Xu, G. Hu, E. Tasciotti, V.-P.J.N.c. Lehto, Cell membrane
coating integrity affects the internalization mechanism of biomimetic nanoparticles, Nat. Commun 12(1) (2021) 1-12.
[53] M. Plasil, J. Futas, A. Jelinek, P.A. Burger, P.J.F.i.G. Horin, Comparative Genomics of the Major Histocompatibility Complex (MHC) of Felids, Front Genet 13 (2022).
)
)